<DOC>
	<DOCNO>NCT02904096</DOCNO>
	<brief_summary>The primary objective study evaluate safety Radiesse implantation severe volume loss dorsum hand 6 month treatment .</brief_summary>
	<brief_title>RadiesseÂ® Safety Study For Treatment Hands</brief_title>
	<detailed_description>This 2-year post approval safety ( PAS ) study evaluate Adverse Event ( AE ) rate Merz Hand Grading Scale ( MHGS ) baseline grade 4 hand ( Group A ) compare AE rate MHGS baseline grade 2-3 hand ( Group B ) . Subjects recruit site intention equal number subject Group A Group B . All subject receive initial Radiesse hand treatment hand , 3 retreatments study . Hands assessed evaluator MHGS blind group , treatment detail , time since last treatment , number retreatments .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>1 . Has hand rating 2 , 3 , 4 validate MHGS determine live , masked evaluator . 2 . Is least 22 year age . 3 . Understands accepts obligation receive procedure dorsum hand end study . 4 . Understands accepts obligation logistically able present schedule followup visit meet study requirement . 1 . Was participant Radiesse hand premarket clinical study 2 . Has treat fat injection Radiesse hand , hand deformity , receive surgery dorsum hand . 3 . Has medical condition potential interfere study increase risk AEs .</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>